Effect of a fixed dose combination of perindopril and amlodipine on patients with essential hypertension

Trial Profile

Effect of a fixed dose combination of perindopril and amlodipine on patients with essential hypertension

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms CONTROL
  • Most Recent Events

    • 09 Feb 2016 New trial record
    • 30 Jan 2016 Primary endpoint (The percentage of patients with controlled BP (both systolic and diastolic) at study termination (week 12)) has been met, as per the results published in the Clinical Drug Investigation.
    • 30 Jan 2016 Results published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top